Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa
AS Paller, SV Guide, D Ayala… - Journal of …, 2024 - Taylor & Francis
Background/purpose Dystrophic epidermolysis bullosa (DEB), a rare genetic skin disease
caused by loss-of-function mutations in COL7A1, the gene encoding type VII collagen …
caused by loss-of-function mutations in COL7A1, the gene encoding type VII collagen …
Effectiveness of topical gabapentin in the treatment of vulvodynia: a narrative synthesis
M Ergisi, A Law, N Chaudhari, S Tsatsari… - Frontiers in Pain …, 2023 - frontiersin.org
Vulvodynia is a leading cause of dyspareunia in premenopausal women, causing
considerable morbidity and sexual dysfunction. A multimodal approach is used to treat …
considerable morbidity and sexual dysfunction. A multimodal approach is used to treat …
The Prevalence of Using Traditional, Complementary, and Integrative Medicine by Patients with Epidermolysis Bullosa
Epidermolysis bullosa (EB) is an inherited disease that causes widespread symptoms
characterized by extreme epithelial fragility. This study examined traditional, complementary …
characterized by extreme epithelial fragility. This study examined traditional, complementary …